@pabsgill The #OxfordAstraZeneca COVID-19 vaccine has received the green stamp from #UK authorities for emergency use. It is expected to start rolling out the vaccine from January 4.
@pabsgill The Serum Institute of India (@SerumInstIndia) is hopeful that the India variant, called #COVISHIELD, will receive the required regulatory approval in a ‘few days’.
@pabsgill@SerumInstIndia "We have 40-50 million doses of #Covishield stockpiled. Once we get regulatory approvals in a few days, it will be down to the government to decide how much they can take and how fast." said @SerumInstIndia CEO @adarpoonawalla during a press conference on Monday.
Twenty people with the new strain of COVID-19 have been detected in India, with 14 cases emerging in the last 24 hours, according to the India’s Health Ministry.
Samples from Delhi show the highest frequency with eight cases testing positive for the new strain in the national capital, followed by NIMHANS in Bengaluru with seven positive cases.
➡️India detected its first six cases of the new #COVID19 strain in UK returnees on December 29. According to the Indian government, this is not a cause for concern as far as vaccines as concerned.
➡️“There is no evidence that current vaccines will fail to protect against COVID-19 variants reported from the UK or South Africa,” said K Vijayraghavan, the principal scientific advisor to the Indian government.
It’s been over a month since #farmers arrived at the border of India’s national capital, #NewDelhi, to protest the country’s three new contentious #FarmLaws.